Oncolytics Biotech, Inc.
ONCY
Get informed when a big investor buys or sells
+ FollowMarket Cap$77.28M
Close$
$0.05
93.1% downside
Current Fair Value
93.1% downsideOvervalued by 93.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $77.28 Million |
|---|---|
| Enterprise Value | $73.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.41 |
| Beta | 1.15 |
| Outstanding Shares | 119,739,942 |
Return
| Return on Equity | 560.92% |
|---|---|
| Return on Assets | -450.95% |
| Return on Invested Capital | -1420.73% |
Valuation & Multiples
| P/E Ratio | -3.13 |
|---|---|
| PEG | -5.89 |
| Price to Sales | - |
| Price to Book Ratio | -0.68 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.12 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.54%▲ 0.87% |
|---|---|
| Total Invested | $3.77M▲ 44.60% |
| Investors Holding | 78▲ 21.00% |
ESG Score
No data